(19)

(11)

EP 4 233 071 A1

(12)

(43) Date of publication: 30.08.2023 Bulletin 2023/35 (21) Application number: 21883581.7 (22) Date of filing: 14.10.2021

(51) International Patent Classification (IPC):  G16H 50/20(2018.01) G16H 20/70(2018.01) A61B 5/00(2006.01) G16H 10/60(2018.01) G16H 20/60(2018.01) (52) Cooperative Patent Classification (CPC): G16H 50/20; G16H 10/60; G16H 20/60; G16H 20/70; G16H 20/10; G16H 20/30; G16H 50/30; G16H 80/00 (86) International application number: PCT/US2021/054980 (87) International publication number: WO 2022/086781 (28.04.2022 Gazette 2022/17)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 22.10.2020 US 202063104322 P 08.10.2021 US 202117497499 (71) Applicant: Mahana Therapeutics, Inc. San Francisco, CA 94105 (US)

(72) Inventors: PAULL, Robert Bradley San Francisco, California 94105 (US) KUMAR, Gaurav San Francisco, California 94105 (US) BROWNING, Christopher Michael San Francisco, California 94105 (US) OSER, Megan Leigh San Francisco, California 94105 (US) MONTGOMERY, Ann Harriet San Francisco, California 94105 (US) SHIM, Jennifer Lily San Francisco, California 94105 (US) LEVY, Simon San Francisco, California 94105 (US) (74) Representative: Leonard, Thomas Charles et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL London WC1X 8NL (GB)